First Amendment to ONCOSIGNATURE COMPANION DIAGNOSTIC AgreementOncosignature Companion Diagnostic Agreement • March 28th, 2023 • Acrivon Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 28th, 2023 Company IndustryThis First Amendment to Oncosignature Companion Diagnostic Agreement (the “First Amendment”) is made and entered into as of December 21, 2022 (the “First Amendment Effective Date”) by and between:
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 28th, 2023 • Acrivon Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 28th, 2023 Company Industry JurisdictionThis Executive Employment Agreement (the “Agreement”), is made and entered into this 5th day of October, 2020 (the “Effective Date”), and is by and between Acrivon Therapeutics Inc., a Delaware corporation (“Company”), and Kristina M. Masson (“Executive”).